Search

Manik B Baltaian

from Glendale, CA
Age ~63
Get Report
Also known as:
Manik Baltayan, Baltaian Manik, Sarkisian Manik
Phone and address:
1211 Alma St, Glendale, CA 91202
(818) 548-9054
Related to:
Gabriel BaltiainSarkis BaltaianAngelika Baltaian, 58Lilit Baltaian, 61Sarkisian Manik
Connected to:
Rodolfo Baltajan, 56Ana G Baltar, 65Angel Baltar, 83Beatriz Y Baltar, 55George F Baltar, 81John P Baltar, 108Luis E Baltar, 48Christine M Baltas, 55Stephanie A Baltaxe, 57Adalberto Baltazar, 43

Manik Baltaian Phones & Addresses

  • 1211 Alma St, Glendale, CA 91202 (818) 548-9054
  • 461 Myrtle St, Glendale, CA 91203 (818) 243-6065
  • 458 Lexington Dr, Glendale, CA 91203
  • Palm Springs, CA
  • Palm Desert, CA
  • Encino, CA
  • Los Angeles, CA
  • North Hollywood, CA
  • 461 Myrtle St, Glendale, CA 91203

Work

Company: Customer service associates Position: Customer service engineer

Industries

Electrical/Electronic Manufacturing

Resumes

Resumes

Manik Baltaian Photo 1

Customer Service Engineer

View page
Location:
Glendale, CA
Industry:
Electrical/Electronic Manufacturing
Work:
Customer Service Associates
Customer Service Engineer

Publications

Us Patents

Stable Bactericidal Permeability-Increasing Protein Products And Pharmaceutical Compositions Containing The Same

View page
US Patent:
6433140, Aug 13, 2002
Filed:
Oct 19, 1999
Appl. No.:
09/425034
Inventors:
Georgia Theofan - Torrance CA
Arnold Horwitz - Los Angeles CA
David Burke - Oakland CA
Manik Baltaian - Glendale CA
Lynn Grinna - Middleburg VA
Assignee:
XOMA Corporation - Berkeley CA
International Classification:
C07K 100
US Classification:
530350, 435 71, 435 6, 435 691
Abstract:
Disclosed are novel bactericidal/permeability-increasing (BPI) protein products wherein cysteine residue number 132 or 135 is replaced by another amino acid residue, preferably an alanine or serine residue and/or wherein the leucine residue at position 193 is the carboxy terminal residue. Also disclosed are DNA sequences encoding methods for the production of the same in appropriate host cells, and state homogeneous pharmaceutical compositions containing the analogs suitable for use treatment of gram negative bacterial infection and in sequelae.

Stable Bactericidal/Permeability-Increasing Protein Products And Pharmaceutical Compositions Containing The Same

View page
US Patent:
6828418, Dec 7, 2004
Filed:
Jul 16, 2002
Appl. No.:
10/196460
Inventors:
Georgia Theofan - Torrance CA
Arnold Horwitz - Los Angeles CA
David Burke - Oakland CA
Manik Baltaian - Glendale CA
Lynn Grinna - Middleburg VA
Assignee:
Xoma Corporation - Berkeley CA
International Classification:
A61K 3800
US Classification:
530300, 530350, 514 12, 514 21, 435 71
Abstract:
Disclosed are novel bactericidal/permeability-increasing (BPI) protein products wherein cysteine residue number 132 or 135 is replaced by another amino acid residue, preferably an alanine or serine residue and/or wherein the leucine residue at position 193 is the carboxy terminal residue. Also disclosed are DNA sequences encoding methods for the production of the same in appropriate host cells, and stable homogeneous pharmaceutical compositions containing the analogs suitable for use treatment of gram negative bacterial infection and its sequelae.

Stable Bactericidal/Permeability-Increasing Protein Products And Pharmaceutical Compositions Containing The Same

View page
US Patent:
20060009383, Jan 12, 2006
Filed:
Nov 3, 2004
Appl. No.:
10/980722
Inventors:
Georgia Theofan - Torrance CA, US
Arnold Horwitz - Los Angeles CA, US
David Burke - Oakland CA, US
Manik Baltaian - Glendale CA, US
Lynn Grinna - Middleburg VA, US
International Classification:
A61K 38/16
C07K 14/195
US Classification:
514012000, 530350000
Abstract:
Disclosed are novel bactericidal/permeability-increasing (BPI) protein products wherein cysteine residue number 132 or 135 is replaced by another amino acid residue, preferably an alanine or serine residue and/or wherein the leucine residue at position 193 is the carboxy terminal residue. Also disclosed are DNA sequences encoding methods for the production of the same in appropriate host cells, and stable homogeneous pharmaceutical compositions containing the analogs suitable for use treatment of gram negative bacterial infection and its sequelae.

Stable Bactericidal/Permeability-Increasing Protein Products And Pharmaceutical Compositions Containing The Same

View page
US Patent:
58278168, Oct 27, 1998
Filed:
Jun 6, 1995
Appl. No.:
8/466822
Inventors:
Georgia Theofan - Torrance CA
Arnold Horwitz - Los Angeles CA
David Burke - Oakland CA
Manik Baltaian - Glendale CA
Lynn Grinna - Middleburg VA
Assignee:
Xoma Corporation - Berkeley CA
International Classification:
A61K 3817
US Classification:
514 2
Abstract:
Disclosed are novel bactericidal/permeability-increasing (BPI) protein products wherein cysteine residue number 132 or 135 is replaced by another amino acid residue, preferably an alanine or serine residue and/or wherein the leucine residue at position 193 is the carboxy terminal residue. Also disclosed are DNA sequences encoding methods for the production of the same in appropriate host cells, and stable homogeneous pharmaceutical compositions containing the analogs suitable for use treatment of gram negative bacterial infection and its sequelae.

Stable Bactericidal/Permeability-Increasing Protein Muteins

View page
US Patent:
54200199, May 30, 1995
Filed:
Feb 2, 1993
Appl. No.:
8/013801
Inventors:
Georgia Theofan - Torrance CA
Arnold Horwitz - Los Angeles CA
David Burke - Oakland CA
Manik Baltaian - Glendale CA
Lynn Grinna - Middleburg VA
Assignee:
Xoma Corporation - Berkeley CA
International Classification:
C12P 2106
C12N 1500
C07K 14435
US Classification:
435 691
Abstract:
Disclosed are novel bactericidal/permeability-increasing (BPI) protein products wherein cysteine residue number 132 or 135 is replaced by another amino acid residue, preferably an alanine or serine residue and/or wherein the leucine residue at position 193 is the carboxy terminal residue. Also disclosed are DNA sequences encoding methods for the production of the same in appropriate host cells, and stable homogeneous pharmaceutical compositions containing the analogs suitable for use treatment of gram negative bacterial infection and its sequelae.

Stable Bactericidal/Permeability-Increasing Protein Products And Pharmaceutical Compositions Containing The Same

View page
US Patent:
56748345, Oct 7, 1997
Filed:
Apr 28, 1995
Appl. No.:
8/430417
Inventors:
Georgia Theofan - Torrance CA
Arnold Horwitz - Los Angeles CA
David Burke - Oakland CA
Manik Baltaian - Glendale CA
Lynn Grinna - Middleburg VA
Assignee:
XOMA Corporation - Berkeley CA
International Classification:
A61K 3817
US Classification:
514 2
Abstract:
Disclosed are novel bactericidal/permeability-increasing (BPI) protein products wherein cysteine residue number 132 or 135 is replaced by another amino acid residue, preferably an alanine or serine residue and/or wherein the leucine residue at position 193 is the carboxy terminal residue. Also disclosed are DNA sequences encoding methods for the production of the same in appropriate host cells, and stable homogeneous pharmaceutical compositions containing the analogs suitable for use treatment of gram negative bacterial infection and its sequelae.
Control profile
Manik B Baltaian from Glendale, CA, age ~63 Get Report